A Life Rewritten: KFSHRC Treats Rare Disease After 22 Years of Specialized Care
RIYADH, Saudi Arabia, Aug. 24, 2025 (GLOBE NEWSWIRE) -- In a rare…
ZEISS announces CE mark for CIRRUS PathFinder AI tool with automated OCT assessment
Fully integrated AI decision support tool flags B scans that may require…
Erdem Hospital Performs First-of-Its-Kind Spinal Revision Surgery
Photo: Erdem Hospital via FL Communications ISTANBUL, Aug. 13, 2025 (GLOBE NEWSWIRE)…
SOPHiA GENETICS expands collaboration with AstraZeneca using AI to improve breast cancer patient outcomes
BOSTON and ROLLE, Switzerland, Aug. 5, 2025 /PRNewswire/ -- SOPHiA GENETICS (Nasdaq:…
Leo Cancer Care Receives FDA 510(k) Clearance for Marie – A Revolutionary Upright Radiotherapy Platform
MIDDLETON, Wis., July 29, 2025 /PRNewswire/ -- Leo Cancer Care, a leader in…
Medit to Reveal New Medit i900 Mobility, Powered by True Mobility
SEOUL, South Korea, Aug. 1, 2025 /PRNewswire/ -- Medit (www.medit.com), a global leader in…
BostonGene Receives Frost & Sullivan’s 2025 North American Enabling Technology Leadership Award for Redefining Precision Oncology with AI and Multiomics Innovation
BostonGene's comprehensive AI-powered platform integrates multiomics data to accelerate discovery, reduce development…
Golden Age Health and Innostellar Biotherapeutics Sign Exclusive 10-Year Collaboration to Accelerate LX-101 Gene Therapy for Inherited Retinal Dystrophies due to RPE 65 gene mutation in Mainland China
SHANGHAI--(BUSINESS WIRE)--Golden Age Health Pte. Ltd. (“GAH”) and Innostellar Biotherapeutics Co., Ltd.…
Australian Dentists Endorse Smartee’s Mandibular Repositioning Technology at Global Symposium in Kunming
Clinicians praise the S8-SGTB appliance for accelerating outcomes, improving patient satisfaction, and…
NKGen Biotech Administers First Dose of Troculeucel to Alzheimers Patient Who Continued to Decline Cognitively While on Prior Amyloid-Targeting Therapy
July 10, 2025 16:30 ET | Source: NKGen Biotech, Inc. SANTA ANA,…